Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Work In Process (2016 - 2019)

Plus Therapeutics (PSTV) has disclosed Work In Process for 9 consecutive years, with $662000.0 as the latest value for Q1 2019.

  • Quarterly Work In Process rose 18.85% to $662000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $662000.0 through Mar 2019, up 18.85% year-over-year, with the annual reading at $555000.0 for FY2018, 23.13% down from the prior year.
  • Work In Process for Q1 2019 was $662000.0 at Plus Therapeutics, up from $555000.0 in the prior quarter.
  • The five-year high for Work In Process was $1.4 million in Q1 2015, with the low at $418000.0 in Q3 2018.
  • Average Work In Process over 5 years is $876588.2, with a median of $839000.0 recorded in 2017.
  • The sharpest move saw Work In Process soared 194.59% in 2015, then plummeted 53.21% in 2018.
  • Over 5 years, Work In Process stood at $816000.0 in 2015, then increased by 25.12% to $1.0 million in 2016, then decreased by 29.29% to $722000.0 in 2017, then fell by 23.13% to $555000.0 in 2018, then increased by 19.28% to $662000.0 in 2019.
  • According to Business Quant data, Work In Process over the past three periods came in at $662000.0, $555000.0, and $418000.0 for Q1 2019, Q4 2018, and Q3 2018 respectively.